Knight Therapeutics Inc.

TSX Exchange | May 28, 2020, 2:39 AM EDT | Real-time price

GUD $ 7.53 RT
-0.07 (-0.9211%)
Day Low: 7.30
Day High: 7.58
Detailed Quote
Open: 7.58
High: 7.58
Beta: 0.8121
Listed Shares Out.1: 130,844,876
Total Shares (All Classes)2: 135,381,707
Prev. Close: 7.60
Low: 7.30
VWAP: 7.4345
Market Cap1: 985,261,916
Market Cap (All Classes)2*: 1,019,424,254
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: 74.50
EPS: 0.10
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 1.257
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, an... More

News Headlines for Knight Therapeutics Inc.
News Headlines for Knight Therapeutics Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.